Suzanne Elliott

4.0k citations

44 papers · 2.8k indexed · h-index 30

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Virology top 5%

Papers in

Immunology 20
- Immunotherapy and Immune Responses 10
- T-cell and B-cell Immunology 9
- Immune Cell Function and Interaction 8
Virology 3

Co-authors: Denis J. Moss Rajiv Khanna Andreas Suhrbier Paul Griffin Martina A. Sherritt James McCarthy Scott R. Burrows Christopher Schmidt
Journals: Vaccine (4 papers)Journal of Virology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)The Journal of Immunology (3 papers)The Journal of Infectious Diseases (3 papers)
Partner nations: Australia United States Switzerland

In The Last Decade

Suzanne Elliott

44 papers receiving 2.7k citations

Peers

Countries citing papers authored by Suzanne Elliott

Since Specialization

Citations

This map shows the geographic impact of Suzanne Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Elliott more than expected).

Fields of papers citing papers by Suzanne Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Elliott. The network helps show where Suzanne Elliott may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suzanne Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne Elliott Line = papers co-authored together Suzanne Elliott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prevalence of hepatitis C virus exposure and infection among Indigenous and tribal populations: a global systematic review and meta-analysis Public Health ·Suzanne Elliott, Erin Flynn, Shilu Mathew, Behzad Hajarizadeh, Marianne Martinello, Handan Wand, James Ward	2024	1
2	A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions Journal of Clinical Investigation ·Katharine A. Collins, Claire Wang, Matthew Adams, Robbert Verhulst, Greg Robinson, کبری رشیدی, Suzanne Elliott, Meng Wanxing, David S. Khoury, E Ballard, Todd Shelper, Leonardo Lucantoni, Vicky M. Avery, Stephan Chalon, Joerg J. Moehrle, James McCarthy	2020	21
3	A controlled human malaria infection model enabling evaluation of transmission-blocking interventions Journal of Clinical Investigation ·Katharine A. Collins, Claire Wang, Matthew Adams, Robbert Verhulst, کبری رشیدی, Suzanne Elliott, Isaie J. Reuling, Teun Bousema, Robert W. Sauerwein, Stephan Chalon, Jörg J. Möhrle, James McCarthy	2018	79
4	Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial PLoS ONE ·Silvana Sekuloski, Michael R. Batzloff, Paul Griffin, William Parsonage, Suzanne Elliott, Jon Hartas, Peter O’Rourke, Louise Marquart, Manisha Pandey, Zihan Asagaf, Jonathan R. Carapetis, James McCarthy, Michael F. Good	2018	68
5	Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study The Lancet Infectious Diseases ·James McCarthy, Julie Lotharius, Thomas Rückle, Stephan Chalon, Margaret A. Phillips, Suzanne Elliott, Silvana Sekuloski, Paul Griffin, Caroline L. Ng, David A. Fidock, Louise Marquart, Noelle S. Williams, Nathalie Gobeau, Lidiya Bebrevska, Maria Rosario, Kennan C. Marsh, Jörg J. Möhrle	2017	82
6	Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects Vaccine ·Paul Griffin, Suzanne Elliott, Kenia G. Krauer, Cristyn Davies, S. Rachel Skinner, Christopher D. Anderson, Angus H. Forster	2017	39
7	Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission PLoS neglected tropical diseases ·Paul Griffin, Cielo Pasay, Suzanne Elliott, Silvana Sekuloski, Maggy T. Sikulu-Lord, Leon E. Hugo, David S. Khoury, Deborah Cromer, Miles P. Davenport, Jetsumon Sattabongkot, Karen Ivinson, Christian F. Ockenhouse, James McCarthy	2016	36
8	Fasting increases serum bilirubin levels in clinically normal, healthy males but not females: a retrospective study from phase I clinical trial participants Journal of Clinical Pathology ·Paul Griffin, Suzanne Elliott, Kerry J. Manton	2014	9
9	Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults Vaccine ·Mark A. Pierce, Ruth D. Ellis, Amna Amin, Elissa Malkin, E L Tierney, Kazutoyo Miura, Michael P. Fay, Joanne Marjason, Suzanne Elliott, Gregory Mullen, Kelly M. Rausch, Daming Zhu, Carole A. Long, Louis H. Miller	2010	23
10	Prime Boost Vaccination Strategies: CD8 T Cell Numbers, Protection, and Th1 Bias The Journal of Immunology ·Tonia Woodberry, Joy Gardner, Suzanne Elliott, Y.K. Gritsay, David M. Purdie, Paul Chaplin, Andreas Suhrbier	2003	49
11	Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy Transplantation ·Martina A. Sherritt, Mandvi Bharadwaj, Jacqueline M. Burrows, Stanton D. Hicks, Suzanne Elliott, Joanne E. Davis, Hossein Youzbashizade, R. Slaughter, Scott C. Bell, Andrew Galbraith, Rajiv Khanna, Denis J. Moss	2003	74
12	Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine Cancer Immunology Immunotherapy ·Michael G. E. OʼRourke, Philippe Jarnoux, Catherine Lanagan, Y. Lu, Jie Yang, JOHN R. BELL, Diego Fernando Paz Villota, MA Yue-fen, А Л Румянцев, David M. Purdie, Suzanne Elliott, K.A.O. Ellem, Christopher Schmidt	2003	146
13	Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines European Journal of Immunology ·Martina A. Sherritt, Joy Gardner, Suzanne Elliott, Christopher Schmidt, David M. Purdie, Georgia Deliyannis, William R. Heath, Andreas Suhrbier	2000	20
14	Immunogenicity of an HIV polytope vaccine containing multiple HLA-A2 HIV CD8+ cytotoxic T cell epitopes Journal of Virology ·Tonia Woodberry, Joshua Gardner, Lani R. San Mateo, Damon P. Eisen, Fereshte Ensani, Ian A. Ramshaw, Scott Thomson, Rosemary Ffrench, Suzanne Elliott, Hüseyin Firat, François A. Lemonnier, Andreas Suhrbier	1999	1
15	Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems Vaccine ·Suzanne Elliott	1999	32
16	Delivery of Multiple CD8 Cytotoxic T Cell Epitopes by DNA Vaccination The Journal of Immunology ·Scott Thomson, Martina A. Sherritt, Сёмич Юлия Игоревна, Suzanne Elliott, Denis J. Moss, Germain J. P. Fernando, Lorena E. Brown, Andreas Suhrbier	1998	134
17	Dominant Cytotoxic T Lymphocyte Response to the Immediate‐EarlyTrans‐ Activator Protein, BZLF1, in Persistent Type A or B Epstein‐Barr Virus Infection The Journal of Infectious Diseases ·Suzanne Elliott, Stephanie J. Pye, Christopher Schmidt, Simone Cross, Sharon L. Silins, I S Misko	1997	17
18	Human leukocyte antigen phenotype imposes complex constraints on the antigen‐specific cytotoxic T lymphocyte repertoire European Journal of Immunology ·Scott R. Burrows, Sharon L. Silins, Simone Cross, Chen Au Peh, Maureen Rischmueller, Jacqueline M. Burrows, Suzanne Elliott, James McCluskey	1997	36
19	Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. The Journal of Experimental Medicine ·Sharon L. Silins, Simone Cross, Suzanne Elliott, Stephanie J. Pye, Scott R. Burrows, Jacqueline M. Burrows, Denis J. Moss, Victor Argaet, I S Misko	1996	72
20	Strategies Involved in Developing an Effective Vaccine for EBV-Associated Diseases Advances in cancer research ·Denis J. Moss, Christopher Schmidt, Suzanne Elliott, Andreas Suhrbier, Scott R. Burrows, Rajiv Khanna	1996	39

About Suzanne Elliott

Suzanne Elliott is a scholar working on Immunology, Virology, Public Health, Environmental and Occupational Health, Oncology and Pharmacology, having authored 44 papers that have together received 2.8k indexed citations. Recurring topics across this work include Malaria Research and Control (13 papers), Mosquito-borne diseases and control (10 papers), vaccines and immunoinformatics approaches (10 papers), Viral-associated cancers and disorders (10 papers), Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Immunology (1.3k citations), Virology (198 citations), Public Health, Environmental and Occupational Health (1.0k citations), Oncology (925 citations) and Parasitology (164 citations). Suzanne Elliott has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Denis J. Moss, Rajiv Khanna, Andreas Suhrbier, Paul Griffin, Martina A. Sherritt, James McCarthy, Scott R. Burrows, Christopher Schmidt, Stephanie J. Pye and Silvana Sekuloski. Their work appears in journals such as Vaccine, Journal of Virology, Antimicrobial Agents and Chemotherapy, The Journal of Immunology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact